Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $318,549 | 1 | 97.1% |
| Food and Beverage | $6,726 | 278 | 2.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,290 | 3 | 0.4% |
| Education | $881.27 | 4 | 0.3% |
| Travel and Lodging | $702.71 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $318,600 | 4 | $0 (2019) |
| NeoTract Inc. | $1,304 | 15 | $0 (2020) |
| NxThera, Inc. | $1,290 | 3 | $0 (2018) |
| Intuitive Surgical, Inc. | $765.94 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $587.73 | 27 | $0 (2022) |
| ABBVIE INC. | $498.39 | 29 | $0 (2024) |
| CIPLA USA INC. | $491.91 | 1 | $0 (2020) |
| PFIZER INC. | $402.81 | 44 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $402.43 | 6 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $341.64 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,327 | 47 | PROCEPT BioRobotics Corporation ($341.56) |
| 2023 | $1,041 | 32 | BIOTISSUE HOLDINGS, INC. ($219.06) |
| 2022 | $806.99 | 37 | ABBVIE INC. ($124.86) |
| 2021 | $595.61 | 19 | Medtronic, Inc. ($190.78) |
| 2020 | $1,308 | 10 | Intuitive Surgical, Inc. ($675.03) |
| 2019 | $2,092 | 67 | NeoTract Inc. ($1,228) |
| 2018 | $320,643 | 56 | Boston Scientific Corporation ($318,585) |
| 2017 | $334.95 | 19 | Astellas Pharma US Inc ($125.48) |
All Payment Transactions
287 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: Oncology | ||||||
| 12/19/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $113.59 | General |
| Category: UROLOGY | ||||||
| 12/19/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Education | Cash or cash equivalent | $31.25 | General |
| Category: UROLOGY | ||||||
| 12/18/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: UROLOGY | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Oncology | ||||||
| 12/05/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $35.17 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.77 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/08/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: HORMONE THERAPY | ||||||
| 09/26/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/19/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $57.81 | General |
| Category: UROLOGY | ||||||
| 09/17/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: HORMONE THERAPY | ||||||
| 09/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Oncology | ||||||
| 08/30/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: UROLOGY | ||||||
| 07/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Oncology | ||||||
| 06/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/14/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: HORMONE THERAPY | ||||||
| 06/14/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/07/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Oncology | ||||||
| 06/03/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,475 | 4,553 | $448,533 | $149,353 |
| 2022 | 22 | 1,405 | 3,876 | $378,141 | $139,679 |
| 2021 | 30 | 2,191 | 5,750 | $474,382 | $210,343 |
| 2020 | 28 | 2,234 | 4,669 | $459,963 | $194,591 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 268 | 468 | $125,274 | $44,483 | 35.5% |
| 97530 | Therapy procedure using functional activities | Office | 2023 | 100 | 1,025 | $81,228 | $25,095 | 30.9% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 62 | 1,225 | $70,350 | $20,981 | 29.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 88 | 93 | $48,188 | $17,674 | 36.7% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 51 | 396 | $28,387 | $8,640 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $25,424 | $8,363 | 32.9% |
| 97162 | Evaluation for physical therapy, typically 30 minutes | Office | 2023 | 86 | 89 | $18,913 | $7,091 | 37.5% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 69 | 78 | $12,744 | $3,622 | 28.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 266 | 424 | $9,861 | $3,533 | 35.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $7,263 | $2,952 | 40.6% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 31 | 97 | $6,047 | $1,789 | 29.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 297 | 498 | $3,984 | $1,695 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 28 | $5,296 | $1,505 | 28.4% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 11 | 11 | $3,356 | $1,316 | 39.2% |
| 97164 | Re-evaluation for physical therapy, typically 20 minutes | Office | 2023 | 11 | 12 | $1,771 | $531.59 | 30.0% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 15 | 15 | $445.36 | $81.62 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 404 | $94,188 | $38,069 | 40.4% |
| 97530 | Therapy procedure using functional activities | Office | 2022 | 83 | 853 | $63,909 | $20,771 | 32.5% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2022 | 56 | 1,034 | $55,680 | $18,764 | 33.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 64 | 70 | $32,828 | $13,393 | 40.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $21,783 | $8,596 | 39.5% |
| 97162 | Evaluation for physical therapy, typically 30 minutes | Office | 2022 | 69 | 70 | $12,964 | $5,651 | 43.6% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2022 | 25 | 212 | $14,164 | $4,921 | 34.7% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2022 | 14 | 14 | $10,945 | $4,448 | 40.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 25 | $9,585 | $4,044 | 42.2% |
About Dr. Benjamin Larson, M.D
Dr. Benjamin Larson, M.D is a Urology healthcare provider based in Murrieta, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1972747988.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Larson, M.D has received a total of $328,149 in payments from pharmaceutical and medical device companies, with $1,327 received in 2024. These payments were reported across 287 transactions from 52 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($318,549).
As a Medicare-enrolled provider, Larson has provided services to 7,305 Medicare beneficiaries, totaling 18,848 services with total Medicare billing of $693,967. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Murrieta, CA
- Active Since 04/22/2009
- Last Updated 09/09/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972747988
Products in Payments
- GENERAL THERAPIES (Device) $318,549
- Rezum (Device) $1,290
- UROLIFT (Device) $993.60
- Da Vinci Surgical System (Device) $765.94
- ZEMDRI (PLAZOMICIN) (Drug) $491.91
- XTANDI (Drug) $421.13
- PROVENGE (Drug) $341.64
- AQUABEAM SYSTEM (Device) $341.56
- UroLift (Device) $334.77
- INTERSTIM (Device) $333.18
- NEOX (Medical Supply) $304.21
- ERLEADA (Drug) $240.95
- LUPRON DEPOT (Drug) $224.58
- GEMTESA (Drug) $208.58
- AVEED (Biological) $208.54
- JELMYTO (Drug) $203.04
- TOVIAZ (Drug) $201.23
- BOTOX (Biological) $174.36
- ORGOVYX (Drug) $166.78
- NOCDURNA (Drug) $135.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Murrieta
Richard Conner, Md, MD
Urology — Payments: $376,037
Monisha Crisell, Md, MD
Urology — Payments: $36,085
Philip Brodak, Md, MD
Urology — Payments: $31,904
Dr. Varun Talanki, M.d, M.D
Urology — Payments: $13,840
Dr. Scott Luttge, M.d., P.a, M.D., P.A
Urology — Payments: $13,313
Dr. Madhumitha Reddy, D.o, D.O
Urology — Payments: $12,035